P. Neužil
Circulation · 2007–2019
A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom P. Neužil trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- John K. Kruschke (in Artificial Intelligence)
Papers from P. Neužil's perspective
Ordered by how strongly the researchers P. Neužil trusts endorse each paper. Same corpus, a different order for every researcher.
- Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation (Circulation)
- Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. (Journal of the American Medical Association (JAMA))
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
- Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study (Circulation)
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (European Heart Journal)
- Amiodarone versus sotalol for atrial fibrillation. (New England Journal of Medicine)
- Bayesian data analysis.
- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation (Annals of Internal Medicine)
- Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (Journal of the American Medical Association (JAMA))
- Bayesian clinical trials
Their papers
- Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation. (2019) — 600 citations
- 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. (2017) — 947 citations
- Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial (2016) — 745 citations
- A Leadless Intracardiac Transcatheter Pacing System. (2016) — 785 citations
- Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (2014) — 935 citations
- Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). (2013) — 720 citations
- Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial (2013) — 625 citations
- Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry (2011) — 889 citations
- Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. (2010) — 1,220 citations
- Prophylactic catheter ablation for the prevention of defibrillator therapy. (2007) — 815 citations